| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
An2 Therapeutics, Inc. (ANTX) has 15 insiders with recent SEC Form 4 filings, including 18 buys and 4 sells. ANTX is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 3.22M | $14.83M | - | |
| Other | 92.0K | $423.2K | - | |
| Dir | 79.1K | $363.8K | - | |
| CFO | 73.7K | $338.9K | - | |
| Other | 67.2K | $309.0K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan 3, 2025 | Chanda Sanjay55 | Chief Development Officer | Sell | 2,957 | $1.34 | $3,965.34 | -9.0% | -1.4% | -21.8% | |
| Jan 3, 2025 | Day Lucy55 | Chief Financial Officer | Sell | 2,957 | $1.34 | $3,965.34 | -8.3% | -1.4% | -21.8% | |
| Jan 3, 2025 | Prior Stephen David60 | Chief Strategy Officer | Sell | 2,029 | $1.34 | $2,720.89 | -5.7% | -1.4% | -21.8% | |
| Jan 3, 2025 | Eizen Joshua M60 | See Remarks | Sell | 9,663 | $1.34 | $12,958.08 | -7.6% | -1.4% | -21.8% | |
| Dec 10, 2024 | Readnour Robin Shane52 | Director | Buy | 60,000 | $1.45 | $86,708.01 | +1.7% | -10.6% | -21.9% | |
| Nov 27, 2024 | Zakrzewski Joseph S55 | Director | Buy | 2,000 | $1.40 | $2,800.00 | +1.6% | -19.0% | -20.4% | |
| Nov 27, 2024 | Readnour Robin Shane52 | Director | Buy | 75,000 | $1.41 | $105,685.00 | +3.4% | -19.0% | -20.4% | |
| Nov 20, 2024 | Readnour Robin Shane52 | Director | Buy | 200,000 | $1.07 | $213,127.50 | +10.3% | -12.3% | -16.9% | |
| Nov 19, 2024 | Zakrzewski Joseph S55 | Director | Buy | 25,000 | $1.00 | $25,046.00 | +11.6% | +7.5% | +1.9% | |
| Nov 18, 2024 | Easom Eric74 | Chief Executive Officer | Buy | 50,000 | $1.00 | $49,970.00 | +4.9% | +14.0% | +12.0% |